nach oben

Erschienen in:

09.10.2017 | Original articles

Vitamin D deficiency and functional response to CRT in heart failure patients

verfasst von: Associate Professor A. Separham, MD, Associate Professor L. Pourafkari, MD, FACC, Prof. B. Kazemi, MD, Y. Haghizadeh, MD, Prof. F. Akbarzadeh, MD, Prof. M. Toufan, MD, Assistant Professor H. Sate, MD, Prof. N. D. Nader, MD, PhD, FACC, FCCP

Erschienen in: Herz | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Vitamin D deficiency has been associated with a poor outcome in patients with heart failure (HF). We examined the role of vitamin D in the response of HF patients to cardiac resynchronization therapy (CRT).

Methods

The study comprised 50 patients (30 men and 20 women) with HF undergoing CRT implantation who were prospectively enrolled. Response to CRT was defined as a combination of ≥15% reduction in left ventricular end-systolic volume (LVESV) and ≥10% improvement in the 6‑Minute Walk Test within 6 months. Patients were grouped based on their levels of vitamin D prior to CRT implantation. Clinical and echocardiographic examinations were performed prior to and 6 months after the procedure.

Results

Of the patients, 11 (22%) failed to respond to CRT; two patients died within 6 months and an additional nine patients showed no improvement in the 6‑Minute Walk Test and no reduction in their baseline LVESV. A comparison was made between 25 patients with sufficient levels of vitamin D and 25 patients with insufficient levels. Nine patients (36%) in the “insufficient” group and two patients (8%) in the “sufficient” group failed to respond to CRT implantation (p = 0.037).

Conclusion

Adequate serum concentrations of vitamin D play a significant role in improving the functional status of patients with systolic HF following CRT implantation.

Roger VL (2013) Epidemiology of heart failure. Circ Res 113:646–659. https://doi.org/10.1161/CIRCRESAHA.113.300268 CrossRefPubMedPubMedCentral

Costanzo MR (2017) Cardiac resynchronization therapy in women. Heart Fail Clin 13:165–178. https://doi.org/10.1016/j.hfc.2016.07.013 CrossRefPubMed

Daubert C, Behar N, Martins RP, Mabo P, Leclercq C (2017) Avoiding non-responders to cardiac resynchronization therapy: a practical guide. Eur Heart J 38:1463–1472. https://doi.org/10.1093/eurheartj/ehw270 CrossRefPubMed

Auricchio A, Prinzen FW (2011) Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues. Circ J 75:521–527CrossRef

Carita P, Corrado E, Pontone G, Curnis A, Bontempi L, Novo G, Guglielmo M, Ciaramitaro G, Assennato P, Novo S, Coppola G (2016) Non-responders to cardiac resynchronization therapy: insights from multimodality imaging and electrocardiography. A brief review. Int J Cardiol 225:402–407. https://doi.org/10.1016/j.ijcard.2016.09.037 CrossRefPubMed

Yu Z, Chen X, Han F, Qin S, Li M, Wu Y, Su Y, Ge J (2017) Electro-echocardiographic indices to predict cardiac resynchronization therapy non-response on non-ischemic cardiomyopathy. Sci Rep 7:44009. https://doi.org/10.1038/srep44009 CrossRefPubMedPubMedCentral

Rinkuniene D, Bucyte S, Ceseviciute K, Abramavicius S, Baronaite-Dudoniene K, Laukaitiene J, Kazakevicius T, Zabiela V, Sileikis V, Puodziukynas A, Jurkevicius R (2014) Predictors of positive response to cardiac resynchronization therapy. BMC Cardiovasc Disord 14:55. https://doi.org/10.1186/1471-2261-14-55 CrossRefPubMedPubMedCentral

Qiao Q, Ding LG, Hua W, Chen KP, Wang FZ, Zhang S (2011) Potential predictors of non-response and super-response to cardiac resynchronization therapy. Chin Med J (Engl) 124:1338–1441

Shanks M, Delgado V, Ng AC, Auger D, Mooyaart EA, Bertini M, Marsan NA, van Bommel RJ, Holman ER, Poldermans D, Schalij MJ, Bax JJ (2011) Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapy. Am Heart J 161:552–557. https://doi.org/10.1016/j.ahj.2010.11.011 CrossRefPubMed

10.

Kamiyama Y, Suzuki H, Yamada S, Kaneshiro T, Takeishi Y (2015) Serum phosphate levels reflect responses to cardiac resynchronization therapy in chronic heart failure patients. J Arrhythm 31(1):38–42. https://doi.org/10.1016/j.joa.2014.06.006 CrossRefPubMed

11.

Cai C, Hua W, Ding LG, Wang J, Chen KP, Yang XW, Liu ZM, Zhang S (2014) High sensitivity C‑reactive protein and cardfiac resynchronization therapy in patients with advanced heart failure. J Geriatr Cardiol 11(4):296–302. https://doi.org/10.11909/j.issn.1671-5411.2014.04.004 CrossRefPubMedPubMedCentral

12.

Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87(4):1080S–1086SCrossRef

13.

Wimalawansa SJ (2016) Non-musculoskeletal benefits of vitamin D. J Steroid Biochem Mol Biol. https://doi.org/10.1016/j.jsbmb.2016.09.016 CrossRefPubMed

14.

Separham A, Sohrabi B, Pourafkari L, Sepasi N, Ghaffari S, Aslanabadi N, Nader ND (2017) Vitamin D is a predictor of ST segment resolution and infarct size following thrombolysis in patients with acute ST elevation myocardial infarction. Turk Kardiyol Dern Ars 45(4):324–332. https://doi.org/10.5543/tkda.2017.17737 CrossRefPubMed

15.

Judd SE, Tangpricha V (2009) Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 338(1):40–44. https://doi.org/10.1097/MAJ.0b013e3181aaee91 CrossRefPubMedPubMedCentral

16.

Beveridge LA, Witham MD (2013) Vitamin D and the cardiovascular system. Osteoporos Int 24(8):2167–2180. https://doi.org/10.1007/s00198-013-2281-1 CrossRefPubMed

17.

Saponaro F, Marcocci C, Zucchi R, Prontera C, Clerico A, Scalese M, Frascarelli S, Saba A, Passino C (2017) Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients’ survival. Endocrine. https://doi.org/10.1007/s12020-017-1282-9 CrossRefPubMed

18.

Belen E, Sungur A, Sungur MA (2016) Vitamin D levels predict hospitalization and mortality in patients with heart failure. Scand Cardiovasc J 50(1):17–22. https://doi.org/10.3109/14017431.2015.1098725 CrossRefPubMed

19.

Witte KK, Byrom R, Gierula J, Paton MF, Jamil HA, Lowry JE, Gillott RG, Barnes SA, Chumun H, Kearney LC, Greenwood JP, Plein S, Law GR, Pavitt S, Barth JH, Cubbon RM, Kearney MT (2016) Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study. J Am Coll Cardiol 67(22):2593–2603. https://doi.org/10.1016/j.jacc.2016.03.508 CrossRefPubMedPubMedCentral

20.

Sunman H, Ozkan A, Yorgun H, Canpolat U, Maharjan N, Asil S, Kaya EB, Bayrak T, Tokgozoglu L, Ozkara A, Aytemir K, Oto A (2016) Vitamin D levels predict the response to cardiac resynchronization therapy in patients with systolic heart failure. Turk Kardiyol Dern Ars 44(8):670–676. https://doi.org/10.5543/tkda.2016.28848 CrossRefPubMed

21.

Epstein AE, DiMarco JP, Ellenbogen KA et al (2013) 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 61(3):e6–75. https://doi.org/10.1016/j.jacc.2012.11.007 CrossRefPubMed

22.

Niafar M, Pourafkari L, Aminmozaffari S, Nader ND (2016) Association of vitamin D deficiency and thyroid function in postmenopausal women. Adv Pharm Bull 6(4):639–644. https://doi.org/10.15171/apb.2016.078 CrossRefPubMedPubMedCentral

23.

Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. https://doi.org/10.1056/NEJMra070553 CrossRefPubMed

24.

Simpson RU (2011) Selective knockout of the vitamin d receptor in the heart results in cardiac hypertrophy: is the heart a drugable target for vitamin D receptor agonists? Circulation 124(17):1808–1810. https://doi.org/10.1161/CIRCULATIONAHA.111.061234 CrossRefPubMedPubMedCentral

25.

Meredith AJ, McManus BM (2013) Vitamin D in heart failure. J Card Fail 19(10):692–711. https://doi.org/10.1016/j.cardfail.2013.09.002 CrossRefPubMed

26.

Boxer RS, Kenny AM, Cheruvu VK, Vest M, Fiutem JJP II (2010) Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure. Am Heart J 160(5):893–899. https://doi.org/10.1016/j.ahj.2010.08.004 CrossRefPubMedPubMedCentral

27.

Zittermann A, Schleithoff SS, Koerfer R (2006) Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev 11(1):25–33. https://doi.org/10.1007/s10741-006-9190-8 CrossRefPubMed

28.

Liu LC, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, Sillje HH, van Gilst WH, Jaarsma T, de Boer RA (2011) Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail 13(6):619–625. https://doi.org/10.1093/eurjhf/hfr032 CrossRefPubMed

29.

de Borst MH, Vervloet MG, ter Wee PM, Navis G (2011) Cross talk between the renin-angiotensin-aldosterone system and vitamin D‑FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol 22(9):1603–1609. https://doi.org/10.1681/ASN.2010121251 CrossRefPubMedPubMedCentral

30.

Zhang J, Ye J, Guo G, Lan Z, Li X, Pan Z, Rao X, Zheng Z, Luo F, Lin L, Lin Z, Xue Y (2016) Vitamin D status is negatively correlated with insulin resistance in Chinese type 2 diabetes. Int J Endocrinol 2016:1794894. https://doi.org/10.1155/2016/1794894 CrossRefPubMedPubMedCentral

31.

Amer M, Qayyum R (2012) Relation between serum 25-hydroxyvitamin D and C‑reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 109(2):226–230. https://doi.org/10.1016/j.amjcard.2011.08.032 CrossRefPubMed

32.

Kim SH, Baek MS, Yoon DS, Park JS, Yoon BW, Oh BS, Park J, Kim HJ (2014) Vitamin D inhibits expression and activity of matrix metalloproteinase in human lung fibroblasts (HFL-1) cells. Tuberc Respir Dis (Seoul) 77(2):73–80. https://doi.org/10.4046/trd.2014.77.2.73 CrossRef

33.

Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Givtaj N, Sameie N, Sadeghpour A, Haghjoo M (2009) Prediction of response to cardiac resynchronization therapy using simple electrocardiographic and echocardiographic tools. Europace 11(10):1330–1337. https://doi.org/10.1093/europace/eup258 CrossRefPubMed

34.

Chatterjee NA, Singh JP, Szymonifka J, Deano RC, Thai WE, Wai B, Min JK, Januzzi JL, Truong QA (2016) Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study. Int J Cardiol 205:43–49. https://doi.org/10.1016/j.ijcard.2015.12.002 CrossRefPubMed

Titel: Vitamin D deficiency and functional response to CRT in heart failure patients
verfasst von: Associate Professor A. Separham, MD
Associate Professor L. Pourafkari, MD, FACC
Prof. B. Kazemi, MD
Y. Haghizadeh, MD
Prof. F. Akbarzadeh, MD
Prof. M. Toufan, MD
Assistant Professor H. Sate, MD
Prof. N. D. Nader, MD, PhD, FACC, FCCP
Publikationsdatum: 09.10.2017
Verlag: Springer Medizin
Erschienen in: Herz / Ausgabe 2/2019
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-017-4630-x

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Evaluation of left ventricular function after percutaneous recanalization of chronic coronary occlusions

Impact of right ventricular diastolic dysfunction on clinical outcomes in inferior STEMI

Critical inflammatory mechanisms underlying arrhythmias

Krebserkrankungen heilen und das Herz schützen